- Home
- FOLD vs RNG Comparison
FOLD vs RNG Comparison
Compare FOLD & RNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- RNG
- Stock Information
- Founded
- FOLD 2002
- RNG 1999
- Country
- FOLD United States
- RNG United States
- Employees
- FOLD N/A
- RNG N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- RNG EDP Services
- Sector
- FOLD Health Care
- RNG Technology
- Exchange
- FOLD Nasdaq
- RNG Nasdaq
- Market Cap
- FOLD 2.9B
- RNG 2.3B
- IPO Year
- FOLD 2007
- RNG 2013
- Fundamental
- Price
- FOLD $6.12
- RNG $27.67
- Analyst Decision
- FOLD Buy
- RNG Buy
- Analyst Count
- FOLD 10
- RNG 15
- Target Price
- FOLD $16.22
- RNG $34.00
- AVG Volume (30 Days)
- FOLD 5.5M
- RNG 1.4M
- Earning Date
- FOLD 08-07-2025
- RNG 07-31-2025
- Dividend Yield
- FOLD N/A
- RNG N/A
- EPS Growth
- FOLD N/A
- RNG N/A
- EPS
- FOLD N/A
- RNG N/A
- Revenue
- FOLD $543,141,000.00
- RNG $2,428,240,000.00
- Revenue This Year
- FOLD $19.87
- RNG $5.82
- Revenue Next Year
- FOLD $23.15
- RNG $5.51
- P/E Ratio
- FOLD N/A
- RNG N/A
- Revenue Growth
- FOLD 28.25
- RNG 7.78
- 52 Week Low
- FOLD $5.51
- RNG $20.59
- 52 Week High
- FOLD $12.65
- RNG $42.19
- Technical
- Relative Strength Index (RSI)
- FOLD 51.42
- RNG 48.08
- Support Level
- FOLD $5.66
- RNG $29.41
- Resistance Level
- FOLD $6.45
- RNG $30.22
- Average True Range (ATR)
- FOLD 0.21
- RNG 0.85
- MACD
- FOLD 0.07
- RNG -0.03
- Stochastic Oscillator
- FOLD 64.89
- RNG 35.15
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About RNG RingCentral Inc.
RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.